3 Houston innovators to know this week

hou to know

This week's roundup of Houston innovators includes Pedro Silva of Milkify, Anthony Palmiotto of OpenStax, and Brad Deutser of Deutser. Photos courtesy

Editor's note: In this week's roundup of Houston innovators to know, I'm introducing you to three local innovators across industries — from femtech to edtech — recently making headlines in Houston innovation.

Pedro Silva, CEO and co-founder of Milkify

Pedro Silva of Milkify join the Houston Innovators Podcast to discuss the impact of their successful Shark Tank experience. Photo courtesy of Milkify

While Milkify's founders — husband and wife team Pedro Silva and Berkley Luck — secured partners on a popular business pitch and investment show, the entire experience almost didn't happen.

Silva and Luck, who got her PhD in molecular and biomedical s at Baylor College of Medicine, founded the company to provide breast milk freeze drying as a service to Houston-area families. Now, Milkify has customers across the country, but the duo didn't know if going through the process would be worth the investment and publicity, or if it would just be a distraction.

"The competitor in me wanted to be the first breast milk company to go on the show and to tell our story to the world — to show the world what my wife came up with that we thought was so great," Silva says on the Houston Innovators Podcast. "It was probably the scariest 45 minutes of my life." Read more.

Anthony Palmiotto, director of higher education at OpenStax

OpenStax, founded out of Rice University, has continued its growth, adding new partners and textbooks. Photo via openstax.org

In an effort to combat the hefty price tag of assigned texts, OpenStax, a nonprofit education startup out of Rice University, which is on a mission to increase educational access for all, seeks to democratize high-quality education by offering free, peer-reviewed, openly licensed textbooks for students and knowledge seekers across the globe.

This month, OpenStax will add to its 57 open education resources, or OER, titles with a full version of John McMurry's popular pre-med textbook, Organic Chemistry, under an open license to honor his late son, Peter, who passed away in 2019 after losing his battle with cystic fibrosis.

“Before the nursing books, we were doing business books,” Anthony Palmiotto, director of higher education at OpenStax, tells InnovationMap. “Murry’s book builds out our science offerings, so we're thinking about the different areas that students take that can be barriers for them to move up in education and succeed. From there, we’ll continue to think about how a free textbook can help students through that process.” Read more.

Brad Deutser, founder and CEO of Deutser

In his new book, Houstonian Brad Deutser explores how increasingly important a sense of belonging is in the workplace. Photo courtesy

Last week, Houstonian and business consultant Brad Deutser published his book, BELONGING RULES: Five Crucial Actions that Build Unity and Foster Performance. In a guest column for InnovationMap, Deutser writes of the importance of belonging in the workplace with his colleague Isabel Bilotta, managing consultant and head of learning and innovation at Deutser's learning initiative.

"Although there are many definitions out there, we define belonging as where we hold space for something of shared importance," the article reads. "It is where we come together on values, purpose, and identity; a space of acceptance where agreement is not required but a shared framework is understood; where there is an invitation into the space; an intentional choice to take part in; something vital to a sense of connection, security, and acceptance." Read more.

OpenStax, founded out of Rice University, has continued its growth, adding new partners and textbooks. Photo via openstax.org

Growing Houston tech nonprofit expands access to textbooks for college students

openstax updates

If everyone that attended a college or university were polled, they’d all likely agree that one of the worst parts of the experience was the rising costs of textbooks.

In an effort to combat the hefty price tag of assigned texts, OpenStax, a nonprofit education startup out of Rice University, which is on a mission to increase educational access for all, seeks to democratize high-quality education by offering free, peer-reviewed, openly licensed textbooks for students and knowledge seekers across the globe.

This month, OpenStax will add to its 57 open education resources, or OER, titles with a full version of John McMurry's popular pre-med textbook, Organic Chemistry, under an open license to honor his late son, Peter, who passed away in 2019 after losing his battle with cystic fibrosis.

“The author, John McMurry, granted us the ability to publish the 10th edition openly,” Anthony Palmiotto, director of higher education at OpenStax, tells InnovationMap. “So, the most widely used organic chemistry textbook went from being one of the most expensive undergraduate texts on the market (almost $100), to a free and open text, making this a watershed moment for OER.”

This school year, OpenStax is adding 16 academic institutions onto its platform, including Georgia State University, Southwest Texas Junior College, Texas A&M University-Commerce, University of San Diego, and more. It's the largest batch of new schools OpenStax has onboarded in a year, Palmiotto says in a news release.

Founded to increase access

Richard Baraniuk, a professor of Electrical and Computer Engineering at Rice University, founded OpenStax. Photo via rice.edu

OpenStax founder and director Richard Baraniuk, a professor of Electrical and Computer Engineering at Rice University, started the OER publisher in 1999 to remove financial barriers and make educational resources more widely available. Much like increasing access to McMurry’s Organic Chemistry, the goal is to continue to support both learners and educators by providing easily accessible and well-developed materials.

“Our mission is to support all learners in their educational pursuits by providing access to high-quality education,” Palmiotto says. “Richard Baraniuk founded it initially as a way for faculty and others to get their material and their knowledge in the form of textbooks and other learning materials to students.

“And then born out of that, we started this robust textbook development and course material development program where we put out the highest-quality materials we can in a way that fits the way courses are taught. Meaning convenience and scope and sequence and other needs that instructors must use textbooks. So really the access was really the start of it, increasing that and lowering barriers to education, and then a lot flowed from that.”

OpenStax’s library of OER titles, which are published under a Creative Commons Attribution license, are free and easily accessible on the go and usable on any device in multiple formats, including digital and PDF.

Funded by philanthropic supporters, OpenStax normally works to openly access five or six books per year, working mostly on introductory courses. Most recently, the Texas Higher Education Coordinating Board funded the publisher to do a series of nursing books, eight in total.

“Before the nursing books, we were doing business books,” Palmiotto says. “Murry’s book builds out our science offerings, so we're thinking about the different areas that students take that can be barriers for them to move up in education and succeed. From there, we’ll continue to think about how a free textbook can help students through that process.”

Tapping into tech

Currently, OpenStax has over 7.5 million users in the formal education space, primarily in higher education introductory courses, as well as grades K–12. Photo via openstax.org

In addition to nursing, OpenStax is working towards releasing books in data science and computer science, including programming, workplace software and, eventually, artificial intelligence.

“AI is a big deal to us,” says Palmiotto. “We're thinking about it a lot, and in the books themselves, we're incorporating as best we can how AI plays into Data Science, Computer Science and Python Programming those. We’re thinking about how AI could be used and will impact programming, for example. But the AI landscape is changing as we go, and that's another reason we don't just put out the books, we maintain them.

“So, we can continually update them. Once we publish, six months later, we can publish updates or additions to reflect what's happening in courses or in professions or in the workforce to reflect how AI is being used as new software is released and so on.”

As OpenStax continues to build on its OER title database, they are using multiple methods of outreach to reach as many people as possible. Currently, they have over 7.5 million users in the formal education space, primarily in higher education introductory courses, as well as grades K–12.

“Over 140 countries are using our material,” says Palmiotto. “We're not as easily able to track how many students have used our material in all those other countries. But that's not the point, we want to put it out there. We know it's being used. We want to help as much as possible. But it is being used in all those countries and in different ways. Some people are translating it. Some people are using it in English. Some people are breaking it up. It just depends on what they need.”

Evolving the industry

OpenStax repeatedly receives feedback from users worldwide that appreciate the openness and availability of their books. Photo via openstax.org

As much as OpenStax is a disrupter to conventional textbook publishers, they would rather work in partnership with publishers like Murry’s former house Cengage rather than outright replacing them.

“What we've tried to do with those publishers is actually partner with them and say, we know that textbook prices were too high,” says Palmiotto. “Some of them partnered with us, Cengage, Riley, some of the other publishers, like Macmillan, incorporate our textbooks into their platforms so that instructors and students have that flexibility even with those publishers.

“Not every publisher wants to do that. That's their choice. But what we've tried to do is say ‘let's make an ecosystem.’ That's what we call it and let them participate in this movement that open education has become.”

With their textbooks on an open forum, it might seem that OpenStax texts would be susceptible to hacking or other unauthorized changes. But, according to Palmiotto, there’s a safeguard to that.

“We keep the standard version,” he says. “That's why a lot of people keep using it because they know that the version that we provide will be the most up-to-date version. But it is openly licensed. So, if we see that a school wants to teach the course in a slightly different way or if they want to recombine two different books to make a different course, take biology and make human biology, or take philosophy and make ethics or something, they can do that.

“But we still retain the standardized version that we redistribute and make sure that that's the high-quality one that people can look to. So nobody is getting back to our version and changing it, but they do have the opportunity to change their own.”

After more than a decade in the space, OpenStax repeatedly receives feedback from users worldwide that appreciate the openness and availability of their books.

“We have some great stories of different learners from all over the world that are non-traditional students facing barriers,” says Palmiotto. “And having a free textbook and not having to choose between food and their book or courseware makes a huge difference in their lives. If they have this flexibility in what they have to purchase, most people appreciate that choice.”

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Greentown Labs names Lawson Gow as its new Houston leader

head of hou

Greentown Labs has named Lawson Gow as its Head of Houston.

Gow is the founder of The Cannon, a coworking space with seven locations in the Houston area, with additional partner spaces. He also recently served as managing partner at Houston-based investment and advisory firm Helium Capital. Gow is the son of David Gow, founder of Energy Capital's parent company, Gow Media.

According to Greentown, Gow will "enhance the founder experience, cultivate strategic partnerships, and accelerate climatetech solutions" in his new role.

“I couldn’t be more excited to join Greentown at this critical moment for the energy transition,” Gow said in a news release. “Greentown has a fantastic track record of supporting entrepreneurs in Houston, Boston, and beyond, and I am eager to keep advancing our mission in the energy transition capital of the world.”

Gow has also held analyst, strategy and advising roles since graduating from Rice University.

“We are thrilled to welcome Lawson to our leadership team,” Georgina Campbell Flatter, CEO of Greentown Labs, added in the release. “Lawson has spent his career building community and championing entrepreneurs, and we look forward to him deepening Greentown’s support of climate and energy startups as our Head of Houston.”

Gow is the latest addition to a series of new hires at Greentown Labs following a leadership shakeup.

Flatter was named as the organization's new CEO in February, replacing Kevin Dutt, Greentown’s interim CEO, who replaced Kevin Knobloch after he announced that he would step down in July 2024 after less than a year in the role.

Greentown also named Naheed Malik its new CFO in January.

Timmeko Moore Love was named the first Houston general manager and senior vice president of Greentown Labs. According to LinkedIn, she left the role in January.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Houston foundation grants $27M to support Texas chemistry research

fresh funding

Houston-based The Welch Foundation has doled out $27 million in its latest round of grants for chemical research, equipment and postdoctoral fellowships.

According to a June announcement, $25.5 million was allocated for the foundation's longstanding research grants, which provide $100,000 per year in funding for three years to full-time, regular tenure or tenure-track faculty members in Texas. The foundation made 85 grants to faculty at 16 Texas institutions for 2025, including:

  • Michael I. Jacobs, assistant professor in the chemistry and biochemistry department at Texas State University, who is investigating the structure and thermodynamics of intrinsically disordered proteins, which could "reveal clues about how life began," according to the foundation.
  • Kendra K. Frederick, assistant professor in the biophysics department at The University of Texas Southwestern Medical Center, who is studying a protein linked to Parkinson’s disease.
  • Jennifer S. Brodbelt, professor in chemistry at The University of Texas at Austin, who is testing a theory called full replica symmetry breaking (fullRSB) on glass-like materials, which has implications for complex systems in physics, chemistry and biology.

Additional funding will be allocated to the Welch Postdoctoral Fellows of the Life Sciences Research Foundation. The program provides three-year fellowships to recent PhD graduates to support clinical research careers in Texas. Two fellows from Rice University and Baylor University will receive $100,000 annually for three years.

The Welch Foundation also issued $975,000 through its equipment grant program to 13 institutions to help them develop "richer laboratory experience(s)." The universities matched funds of $352,346.

Since 1954, the Welch Foundation has contributed over $1.1 billion for Texas-nurtured advancements in chemistry through research grants, endowed chairs and other chemistry-related ventures. Last year, the foundation granted more than $40.5 million in academic research grants, equipment grants and fellowships.

“Through funding basic chemical research, we are actively investing in the future of humankind,” Adam Kuspa, president of The Welch Foundation, said the news release. “We are proud to support so many talented researchers across Texas and continue to be inspired by the important work they complete every day.”

New Houston biotech co. developing capsules for hard-to-treat tumors

biotech breakthroughs

Houston company Sentinel BioTherapeutics has made promising headway in cancer immunotherapy for patients who don’t respond positively to more traditional treatments. New biotech venture creation studio RBL LLC (pronounced “rebel”) recently debuted the company at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Rima Chakrabarti is a neurologist by training. Though she says she’s “passionate about treating the brain,” her greatest fervor currently lies in leading Sentinel as its CEO. Sentinel is RBL’s first clinical venture, and Chakrabarti also serves as cofounder and managing partner of the venture studio.

The team sees an opportunity to use cytokine interleukin-2 (IL-2) capsules to fight many solid tumors for which immunotherapy hasn't been effective in the past. “We plan to develop a pipeline of drugs that way,” Chakrabarti says.

This may all sound brand-new, but Sentinel’s research goes back years to the work of Omid Veiseh, director of the Rice Biotechnology Launch Pad (RBLP). Through another, now-defunct company called Avenge Bio, Veiseh and Paul Wotton — also with RBLP and now RBL’s CEO and chairman of Sentinel — invested close to $45 million in capital toward their promising discovery.

From preclinical data on studies in mice, Avenge was able to manufacture its platform focused on ovarian cancer treatments and test it on 14 human patients. “That's essentially opened the door to understanding the clinical efficacy of this drug as well as it's brought this to the attention of the FDA, such that now we're able to continue that conversation,” says Chakrabarti. She emphasizes the point that Avenge’s demise was not due to the science, but to the company's unsuccessful outsourcing to a Massachusetts management team.

“They hadn't analyzed a lot of the data that we got access to upon the acquisition,” explains Chakrabarti. “When we analyzed the data, we saw this dose-dependent immune activation, very specific upregulation of checkpoints on T cells. We came to understand how effective this agent could be as an immune priming agent in a way that Avenge Bio hadn't been developing this drug.”

Chakrabarti says that Sentinel’s phase II trials are coming soon. They’ll continue their previous work with ovarian cancer, but Chakrabarti says that she also believes that the IL-2 capsules will be effective in the treatment of endometrial cancer. There’s also potential for people with other cancers located in the peritoneal cavity, such as colorectal cancer, gastrointestinal cancer and even primary peritoneal carcinomatosis.

“We're delivering these capsules into the peritoneal cavity and seeing both the safety as well as the immune activation,” Chakrabarti says. “We're seeing that up-regulation of the checkpoint that I mentioned. We're seeing a strong safety signal. This drug was very well-tolerated by patients where IL-2 has always had a challenge in being a well-tolerated drug.”

When phase II will take place is up to the success of Sentinel’s fundraising push. What we do know is that it will be led by Amir Jazaeri at MD Anderson Cancer Center. Part of the goal this summer is also to create an automated cell manufacturing process and prove that Sentinel can store its product long-term.

“This isn’t just another cell therapy,” Chakrabarti says.

"Sentinel's cytokine factory platform is the breakthrough technology that we believe has the potential to define the next era of cancer treatment," adds Wotton.